Agenus | AGEN - Market Capitalization

Stock Price
3.46
Daily Change
-0.10 -2.81%
Monthly
3.90%
Yearly
108.43%
Q1 Forecast
3.45

Agenus reported $1.46B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 1.66B 1.55B Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 220.14B 68B Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
CSL USD 71.32B 15.44B Mar/2026
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 107.89B 7.96B Mar/2026
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Jiangsu Hengrui CNY 345.1B 132.29B Mar/2026
MacroGenics USD 192M 90M Mar/2026
Merck EUR 47.3B 6B Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 240.48B 51.73B Mar/2026
Novavax USD 1.43B 340M Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Veracyte USD 3.33B 627M Dec/2025